HK Stock Market Move | MAOYAN ENT (01896) up more than 3%; Citigroup believes worst time may be over, expected to benefit from film supply this year

MAOYAN ENT (01896) rose more than 3%, as of the time of writing, it increased by 3.06% to HK $7.4, with a turnover of HK$ 2.9987 million. In terms of news, Citibank stated that the company's worst time may have passed. As the largest movie ticketing platform, it is expected to benefit from better movie supply this year, and the company still has a rich lineup of upcoming films. The next catalyst will be the Chinese New Year holiday season. The bank predicts that the total mainland box office in 2025 will reach 50 billion RMB, an increase of 18% year-on-year. The bank has raised its target price for MAOYAN ENT by 2.2%, from HK $9 to HK $9.2, and has included it as the preferred stock in the film industry with a "buy" rating. The company's revenue forecast for 2025 to 2026 has been raised by 2% to 3%; adjusted net profit has been raised by 5% to 9%. EB SECURITIES pointed out that it is recommended to pay attention to the box office performance of the company's reserved films: 1) In the 2025 Spring Festival season, pay attention to "Tang Detectives 1900". The opening day box office of over 1 billion for "Tang Detectives 3" confirms its national popularity, and the online drama of "Tang Detective" has maintained a certain level of popularity for the Tang Detectives IP; "Tang Detectives 1900" with its all-star lineup and comedy attributes is expected to stimulate demand for family-friendly films. 2) Additionally, pay attention to the films expected to be released in 2025, such as "Soy Sauce Garden", "Lychee in Chang'an", "Leisurely Prepared", "Mermaid", "Dumpling Queen", etc.